Program Description: Developing Pluripotent Stem Cell (PSC)-derived cell therapies presents exciting opportunities for novel and potentially curative approaches to intractable diseases, but also unique challenges that accompany a complex biological drug product. By working from the patient backwards, we can mitigate these challenges and optimize cell therapy development when each step is informed by the requirements of the final product. This unique program reverses the traditional “bench-to-bedside” approach by starting with the end goal – a successful and effective cell therapy –  in mind when considering the entire development process.  Connect with global leaders on the frontlines of developing ESC & iPSC-derived cell therapies as we bring together pioneers leading the most advanced clinical trials and innovators developing the next generation of technologies and platforms that will shape the future of the field.